Skip to main content
. 2020 Apr 14;16:281–286. doi: 10.2147/TCRM.S247437

Table 1.

Demographic Data of the Patients Receiving Nalbuphine or Placebo

Group N
(n=105)
Group C
(n=105)
P value
Gender (F/M) 55/50 48/57 0.33
Age 46.9±14.1 47.4±13.4 0.66
Height 165.0±7.0 165.2±6.8 0.87
Weight 63.2±11.6 64.2±10.0 0.49
ASA (Ⅰ/Ⅱ) 25/80 16/89 0.11

Notes: Values are expressed as mean ± standard deviation, gender and ASA physical status as number. No statistical difference was observed in this table.